Impact of beta-myosin heavy chain expression on cardiac function during stress
Maike Krenz, MD and
Jeffrey Robbins, PhD*
Division of Molecular Cardiovascular Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Manuscript received June 23, 2004;
revised manuscript received September 1, 2004,
accepted September 14, 2004.
* Reprint requests and correspondence: Dr. Jeffrey Robbins, Molecular Cardiovascular Biology, MLC 7020, Children's Hospital, 3333 Burnet Avenue, Cincinnati, Ohio 45229-3039
(Email: jeff.robbins{at}cchmc.org).
OBJECTIVES: In failing mouse and human hearts, a shift in myosin heavy chain (MHC) isoform content from alpha to beta can occur. However, the impact of this phenomenon on disease progression is not well understood. Therefore, using transgenic (TG) mice, we tested how a pre-existing shift from alpha- to beta-MHC affects cardiac function under chronic mechanical or pharmacologic cardiovascular stress.
BACKGROUND: Expression of beta-MHC is considered to be energetically favorable, but this might be offset by depressed cardiac function.
METHODS: Transgenic mice with near-complete replacement of the normally predominant alpha- with beta-MHC were subjected to cardiac stress.
RESULTS: At baseline, TG mice show moderately reduced cardiac contractile function but are otherwise healthy with normal ventricular morphology. After four weeks of swimming, both TG and non-TG animals showed a 20% increase in left ventricular (LV)/body weight ratios. The TG hearts displayed mildly greater end-diastolic and end-systolic LV diameters than nontransgenic hearts after training, but no signs of LV failure were observed. However, chronic stimulation with isoproterenol resulted in augmented LV hypertrophy with signs of LV decompensation in TG mice. Furthermore, in a post-infarction failure model, TG hearts displayed accelerated LV dilation and a faster decline of shortening fraction.
CONCLUSIONS: Expression of beta-MHC appears to be disadvantageous to the mice under severe cardiovascular stress, implying that the alpha beta-MHC isoform shift observed in cardiac disease may be a maladaptive response.
|
Abbreviations and Acronyms
| | dP/dtmax = first derivative of left ventricular pressure | | LV = left ventricle/ventricular | | MHC = myosin heavy chain | | NTG = nontransgenic | | TG = transgenic |
|
This article has been cited by other articles:

|
 |

|
 |
 
J. E. Stelzer, H. S. Norman, P. P. Chen, J. R. Patel, and R. L. Moss
Transmural variation in myosin heavy chain isoform expression modulates the timing of myocardial force generation in porcine left ventricle
J. Physiol.,
November 1, 2008;
586(21):
5203 - 5214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. van Rooij, W. S. Marshall, and E. N. Olson
Toward MicroRNA-Based Therapeutics for Heart Disease: The Sense in Antisense
Circ. Res.,
October 24, 2008;
103(9):
919 - 928.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger
Designing Heart Performance by Gene Transfer
Physiol Rev,
October 1, 2008;
88(4):
1567 - 1651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ait Mou, C. Reboul, L. Andre, A. Lacampagne, and O. Cazorla
Late exercise training improves non-uniformity of transmural myocardial function in rats with ischaemic heart failure
Cardiovasc Res,
September 12, 2008;
(2008)
cvn229v3.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wen, J. R. Pinto, A. V. Gomes, Y. Xu, Y. Wang, Y. Wang, J. D. Potter, and W. G. L. Kerrick
Functional Consequences of the Human Cardiac Troponin I Hypertrophic Cardiomyopathy Mutation R145G in Transgenic Mice
J. Biol. Chem.,
July 18, 2008;
283(29):
20484 - 20494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sadayappan, N. Finley, J. W. Howarth, H. Osinska, R. Klevitsky, J. N. Lorenz, P. R. Rosevear, and J. Robbins
Role of the acidic N' region of cardiac troponin I in regulating myocardial function
FASEB J,
April 1, 2008;
22(4):
1246 - 1257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ren, J. Duan, D. P. Thomas, X. Yang, N. Sreejayan, J. R. Sowers, A. Leri, J. Kajstura, F. Gao, and P. Anversa
IGF-I alleviates diabetes-induced RhoA activation, eNOS uncoupling, and myocardial dysfunction
Am J Physiol Regulatory Integrative Comp Physiol,
March 1, 2008;
294(3):
R793 - R802.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Pillai, M. Chen, S. B. Rajamohan, S. Samant, V. B. Pillai, M. Gupta, and M. P. Gupta
Activation of SIRT1, a class III histone deacetylase, contributes to fructose feeding-mediated induction of the {alpha}-myosin heavy chain expression
Am J Physiol Heart Circ Physiol,
March 1, 2008;
294(3):
H1388 - H1397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. G. Haworth
The cell and molecular biology of right ventricular dysfunction in pulmonary hypertension
Eur. Heart J. Suppl.,
December 1, 2007;
9(suppl_H):
H10 - H16.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Krenz, S. Sadayappan, H. E. Osinska, J. A. Henry, S. Beck, D. M. Warshaw, and J. Robbins
Distribution and Structure-Function Relationship of Myosin Heavy Chain Isoforms in the Adult Mouse Heart
J. Biol. Chem.,
August 17, 2007;
282(33):
24057 - 24064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. van Rooij, L. B. Sutherland, X. Qi, J. A. Richardson, J. Hill, and E. N. Olson
Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
Science,
April 27, 2007;
316(5824):
575 - 579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Herron, R. Vandenboom, E. Fomicheva, L. Mundada, T. Edwards, and J. M. Metzger
Calcium-Independent Negative Inotropy by {beta}-Myosin Heavy Chain Gene Transfer in Cardiac Myocytes
Circ. Res.,
April 27, 2007;
100(8):
1182 - 1190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. Laustsen, S. J. Russell, L. Cui, A. Entingh-Pearsall, M. Holzenberger, R. Liao, and C. R. Kahn
Essential Role of Insulin and Insulin-Like Growth Factor 1 Receptor Signaling in Cardiac Development and Function
Mol. Cell. Biol.,
March 1, 2007;
27(5):
1649 - 1664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Jaehnig, A. B. Heidt, S. B. Greene, I. Cornelissen, and B. L. Black
Increased Susceptibility to Isoproterenol-Induced Cardiac Hypertrophy and Impaired Weight Gain in Mice Lacking the Histidine-Rich Calcium-Binding Protein
Mol. Cell. Biol.,
December 15, 2006;
26(24):
9315 - 9326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sadayappan, H. Osinska, R. Klevitsky, J. N. Lorenz, M. Sargent, J. D. Molkentin, C. E. Seidman, J. G. Seidman, and J. Robbins
Cardiac myosin binding protein c phosphorylation is cardioprotective
PNAS,
November 7, 2006;
103(45):
16918 - 16923.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Kuzman, T. A. Thomas, K. A. Vogelsang, S. Said, B. E. Anderson, and A. M. Gerdes
Effects of induced hyperthyroidism in normal and cardiomyopathic hamsters
J Appl Physiol,
October 1, 2005;
99(4):
1428 - 1433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.J. Marian
On Mice, Rabbits, and Human Heart Failure
Circulation,
May 10, 2005;
111(18):
2276 - 2279.
[Full Text]
[PDF]
|
 |
|
|